Aurobindo Pharma's revenue from ARV formulations FY 2013-2022
The revenue from antiretroviral drug formulations of Aurobindo Pharma Limited in fiscal year 2022 was over eight billion Indian rupees. This value was a significant decrease from the previous financial year 2021.